PREVENTION OF EXPERIMENTAL AUTOIMMUNE ARTHRITIS WITH A PEPTIDE FRAGMENT OF TYPE-II COLLAGEN

被引:52
作者
KU, G
KRONENBERG, M
PEACOCK, DJ
TEMPST, P
BANQUERIGO, ML
BRAUN, BS
REEVE, JR
BRAHN, E
机构
[1] UNIV CALIF LOS ANGELES, SCH MED,DEPT MED,DIV RHEUMATOL,1000 VET AVE, RM 32-48, LOS ANGELES, CA 90024 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, JONSSON CANC CTR, DEPT MICROBIOL & IMMUNOL, LOS ANGELES, CA 90024 USA
[3] HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA
[4] WADSWORTH VAMC, CURE, DEPT MED, DIV GASTROENTEROL, LOS ANGELES, CA USA
关键词
COLLAGEN ARTHRITIS; TOLERANCE; T-CELL EPITOPE; ANIMAL MODEL; PEPTIDE THERAPY;
D O I
10.1002/eji.1830230302
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Collagen arthritis is induced in inbred rats with the injection of native type II collagen. The pathogenesis of this experimental autoimmune disease is T cell dependent. This study demonstrates that collagen-specific T cells, derived from pathogenic and nonpathogenic rat T cell lines., both recognize the same peptide epitope. The epitope, consisting of amino acids 58-73 of cyanogen bromide fragment 11 of type II collagen,was as effective as whole collagen in stimulating a panel of collagen-specific rat/mouse T cell hybridomas. This peptide may, therefore, constitute a dominant epitope for CD4+ rat T cells in their response to type II collagen. Administration of the peptide to either neonatal or adult rats prevented the subsequent induction of experimental arthritis with whole collagen, demonstrating that the in vivo response to this dominant epitope is, therefore, relevant in the pathogenesis of arthritis. Despite its ability to prevent collagen-induced arthritis, administration of this peptide in incomplete Freund's adjuvant intradermally did not induce disease.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 49 条